Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PAK2 |
| Upstream (Parents) |
|---|
| (<<) ADAM12 → PAK2 |
| (<<) ADRBK1 → PAK2 |
| (<<) ATF2 → PAK2 |
| (<<) DLAT → PAK2 |
| (<<) DVL3 → PAK2 |
| (<<) EIF2AK2 → PAK2 |
| (<<) GNA13 → PAK2 |
| (<<) HMGCS1 → PAK2 |
| (<<) KCTD5 → PAK2 |
| (<<) LRP5 → PAK2 |
| (<<) MAP2K2 → PAK2 |
| (<<) MAPK14 → PAK2 |
| (<<) MAT2A → PAK2 |
| (<<) PLK1 → PAK2 |
| (<<) RDX → PAK2 |
| (<<) RXRB → PAK2 |
| (<<) TK2 → PAK2 |
| (<<) YWHAE → PAK2 |
| Downstream (Children) |
|---|
| PAK2 → BDH1 (>>) |
| PAK2 → ENTPD7 (>>) |
| PAK2 → EPHB3 (>>) |
| PAK2 → GRHPR (>>) |
| PAK2 → HEY1 (>>) |
| PAK2 → MAP3K1 (>>) |
| PAK2 → MESDC1 (>>) |
| PAK2 → NFKBIZ (>>) |
